Sequential myeloablative autologous stem cell transplantation and reduced intensity allogeneic hematopoietic cell transplantation is safe and feasible in children, adolescents and young adults with poor-risk refractory or recurrent Hodgkin and non-Hodgkin lymphoma

Saved in:

Bibliographic Details
Title:	Sequential myeloablative autologous stem cell transplantation and reduced intensity allogeneic hematopoietic cell transplantation is safe and feasible in children, adolescents and young adults with poor-risk refractory or recurrent Hodgkin and non-Hodgkin lymphoma
Authors:	Satwani, P¹, Jin, Z², Martin, P L³, Bhatia, M¹, Garvin, J H¹, George, D¹, Chaudhury, S⁴, Talano, J⁵, Morris, E⁶, Harrison, L⁶, Sosna, J¹, Peterson, M³, Militano, O⁶, Foley, S⁶, Kurtzberg, J³, Cairo, M S⁷
Source:	Leukemia (08876924). Feb2015, Vol. 29 Issue 2, p448-455. 8p.
Database:	Academic Search Ultimate

Description
ISSN:	08876924
DOI:	10.1038/leu.2014.194